NEW YORK (GenomeWeb News) – GeneNews has accepted subscriptions for a non-brokered private placement of common stock, raising C$2.3 million (US$2.2 million) in gross proceeds.

The amount raised surpasses the proceeds the firm expected to realize when it announced the direct placement two weeks ago. At that time, it said that it expected to raise C$2 million from the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.